A Phase 1 Multiple Dose Study to Compare the Effects of AMG 223 and Sevelamer HCL (Renagel®)

Clinical trial NCT00756860 · COMPLETED

Trial details

NCT number: NCT00756860
Sponsor: Amgen Research (Munich) GmbH
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2008-05-01
Primary completion: 2008-08-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.